In some pathological conditions such as tumors [4, 5], cardiovascular diseases [6, 7], inflammatory diseases [8–11], and autoimmune diseases [12, 13], FASN expression and the content of fatty acid products synthesized from FASN are abnormally changed. This evidence concerns the gene FASN and cardiovascular disorder.